NIH-funded research R01 grant

Understanding how a seizure/relapse drug may help people with alcohol use disorder and PTSD

Official title: Mechanistic Insights into Topiramate Response in Comorbid AUD and PTSD: From patients to cells

Funded at Mayo Clinic Rochester · NIH-11424107 · Data updated 2026-11-12

A Mayo Clinic-led study will explore why a popular anticonvulsant (topiramate) works differently for people who have both alcohol use disorder and PTSD, using patient samples and cell-level analysis to find clues for better treatment.

More PTSD research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startSeptember 1, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$433,056
NIH project number1R01AA033316-01
Project IDNIH-11424107 on NIH RePORTER

Who could benefit from this research

Could help

Adults with comorbid alcohol use disorder and PTSD who are candidates for anticonvulsant therapy and biomarker-informed care.

Less likely to help

Individuals without AUD/PTSD or those not considered for anticonvulsant therapy may not directly benefit.

What this research studies

This project uses patient information and lab models to uncover biological markers and mechanisms that influence how topiramate works in people with both alcohol problems and PTSD. Researchers will study cells derived from patients and apply advanced data approaches to link molecular signals with treatment responses. The work aims to identify markers that could guide personalized treatment choices and improve outcomes for complex cases. The study combines clinical insights from patients with lab-based experiments to bridge bedside and bench biology.

Why it matters

Potential benefit: If successful, patients with AUD and PTSD could receive more precise, effective treatment recommendations based on their biology.

How similar studies have gone: Previous iPSC and multi-omics work has shown promise in linking biology to drug response, supporting a translational path for this approach.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Ho, Ming-Fen — Mayo Clinic Rochester
  • Study coordinator: Ho, Ming-Fen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.